Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GRTS

Gritstone Bio Inc

Jul 26 • 04:00PM ET

0.6525

Dollar change -0.0043
Percentage change -0.65	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF FESM VTWV DFAC GERM BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.30	Insider Own	8.23%	Shs Outstand	108.57M	Perf Week	0.38%
Market Cap	70.84M	Forward P/E	-	EPS next Y	-0.99	Insider Trans	-0.83%	Shs Float	99.64M	Perf Month	-6.79%
Income	-144.89M	PEG	-	EPS next Q	-0.30	Inst Own	38.92%	Short Float	8.12%	Perf Quarter	-14.65%
Sales	0.84M	P/S	84.34	EPS this Y	10.24%	Inst Trans	-3.74%	Short Ratio	4.58	Perf Half Y	-77.11%
Book/sh	0.14	P/B	4.58	EPS next Y	8.28%	ROA	-83.47%	Short Interest	8.09M	Perf Year	-66.54%
Cash/sh	0.44	P/C	1.49	EPS next 5Y	-	ROE	-187.15%	52W Range	0.52 - 3.33	Perf YTD	-68.01%
Dividend Est.	-	P/FCF	-	EPS past 5Y	30.25%	ROI	-131.20%	52W High	-80.41%	Beta	0.50
Dividend TTM	-	Quick Ratio	1.99	Sales past 5Y	230.33%	Gross Margin	-1335.76%	52W Low	25.48%	ATR (14)	0.06
Dividend Ex-Date	-	Current Ratio	1.99	EPS Y/Y TTM	3.54%	Oper. Margin	-19000.00%	RSI (14)	45.63	Volatility	8.29% 9.68%
Employees	231	Debt/Eq	7.40	Sales Y/Y TTM	-83.44%	Profit Margin	-17269.73%	Recom	1.00	Target Price	4.00
Option/Short	Yes / Yes	LT Debt/Eq	6.91	EPS Q/Q	-14.85%	Payout	-	Rel Volume	0.32	Prev Close	0.66
Sales Surprise	-38.96%	EPS Surprise	-6.65%	Sales Q/Q	-90.96%	Earnings	May 09 AMC	Avg Volume	1.76M	Price	0.65
SMA20	1.99%	SMA50	-8.99%	SMA200	-58.87%	Trades		Volume	570,743	Change	-0.65%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-28-24	Initiated	JMP Securities	Mkt Outperform	$4
Mar-31-23	Initiated	Evercore ISI	Outperform
Mar-28-23	Initiated	B. Riley Securities	Buy	$8
Oct-31-22	Initiated	Piper Sandler	Overweight	$6
Aug-22-22	Downgrade	Goldman	Neutral → Sell	$2
Dec-15-21	Resumed	Goldman	Neutral	$15
Oct-15-21	Resumed	BTIG Research	Buy	$20
Jan-20-21	Downgrade	Robert W. Baird	Outperform → Underperform	$8
Jul-26-19	Initiated	Robert W. Baird	Outperform	$17
Mar-15-19	Initiated	Raymond James	Outperform
Mar-07-19	Initiated	H.C. Wainwright	Buy	$17
Oct-23-18	Initiated	Goldman	Neutral	$18
Oct-23-18	Initiated	BTIG Research	Buy	$26

Show Previous Ratings

Jul-25-24 02:38AM	Gritstone Bio Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GRTS (PR Newswire)
Jul-24-24 07:00AM	Gritstone bio to Host Virtual KOL Event to Discuss Unmet Need and Potential Role of Its Personalized Cancer Vaccine, GRANITE, in Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) (GlobeNewswire) -6.48%
Jul-22-24 05:45AM	Gritstone bio, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - GRTS (PR Newswire)
Jul-10-24 12:55PM	Gritstone bio, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky for More Information GRTS (GlobeNewswire)
07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
02:14AM	Loading…
Jul-04-24 02:14AM	Gritstone Bio Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GRTS (PR Newswire)
Jul-02-24 12:20PM	Gritstone bio, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your Rights GRTS (GlobeNewswire)
Jul-01-24 05:45AM	Gritstone bio, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your Rights - GRTS (PR Newswire) -6.13%
Jun-13-24 07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-04-24 04:05PM	Gritstone bio to Participate in Upcoming Investor and Scientific Conferences (GlobeNewswire) +9.22%
May-09-24 08:56PM	GRTS Stock Earnings: Gritstone Bio Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) -19.36%
04:05PM	Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates (GlobeNewswire)
May-02-24 04:05PM	Gritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024 (GlobeNewswire) +10.66%
Apr-30-24 07:00AM	Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024 (GlobeNewswire)
Apr-29-24 07:00AM	Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors (GlobeNewswire)
07:00AM	Loading…
Apr-15-24 07:00AM	Nature Medicine Publishes Interim Results from Gritstone bio's Phase 1/2 Study of Off-the-Shelf Neoantigen Vaccine Platform (SLATE) (GlobeNewswire) -12.15%
Apr-08-24 08:00AM	Gritstone bio to Participate in Upcoming Investor and Scientific Conferences (GlobeNewswire)
07:00AM	Gritstone bio Presents Improvements to EDGE Platform at AACR 2024 (GlobeNewswire)
Apr-04-24 01:32PM	Gritstone (GRTS) Plummets 58% in a Week: Here's Why (Zacks) -13.03%
Apr-02-24 09:16AM	Why Is Gritstone Bio (GRTS) Stock Down 44% Today? (InvestorPlace) -48.94%
Apr-01-24 11:00PM	Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering (GlobeNewswire) -8.56%
04:10PM	Gritstone bio Announces Proposed Public Offering (GlobeNewswire)
04:01PM	Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) (GlobeNewswire)
Mar-19-24 02:49PM	3 Speculative Stocks You Can Buy for $3 or Less (InvestorPlace) +9.72%
Mar-06-24 01:52PM	GRTS Stock Earnings: Gritstone Bio Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) +6.86%
Mar-05-24 04:05PM	Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates (GlobeNewswire)
Feb-29-24 04:05PM	Gritstone bio Announces Workforce Reduction (GlobeNewswire) -27.86%
Feb-21-24 07:00AM	Gritstone bio to Participate in Upcoming Investor and Scientific Conferences (GlobeNewswire)
Feb-12-24 07:00AM	Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial (GlobeNewswire)
Feb-08-24 04:30PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
04:00PM	Loading…
Jan-31-24 04:00PM	3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential (InvestorPlace) -6.27%
Jan-17-24 07:00AM	Gritstone bio to Participate in Upcoming Investor Conference (GlobeNewswire)
Jan-10-24 04:30PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.98%
Dec-07-23 04:30PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-20-23 07:00AM	Gritstone bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-08-23 06:43PM	Gritstone Bio Inc (GRTS) Reports Q3 2023 Financial Results and Progress in Vaccine Development (GuruFocus.com) -7.65% -7.69%
04:05PM	Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates (GlobeNewswire)
Nov-07-23 04:30PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-12-23 05:00PM	Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio's BARDA Award (GlobeNewswire)
Oct-11-23 07:10AM	Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio's Next Generation COVID-19 Vaccine (GlobeNewswire) -10.53%
Oct-10-23 07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-04-23 04:05PM	Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023 (GlobeNewswire) +20.69%
Sep-27-23 04:01PM	Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million (GlobeNewswire) +31.09%
Sep-13-23 04:30PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.14%
Sep-05-23 07:00AM	Gritstone bio to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.01%
Aug-16-23 04:30PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-15-23 07:00AM	Gritstone bio and Genevant Sciences Announce Option and License Agreement (GlobeNewswire)
Aug-09-23 04:05PM	Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates (GlobeNewswire)
Aug-07-23 07:00AM	Gritstone bio Partners with Friends of Cancer Research (Friends) on the ctDNA to Monitor Treatment Response (ctMoniTR) Project (GlobeNewswire) -5.03%
Jul-17-23 07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.66%
Jul-04-23 06:55AM	Gritstone bio (NASDAQ:GRTS) shareholders have endured a 70% loss from investing in the stock three years ago (Simply Wall St.)
Jun-13-23 07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-08-23 07:00AM	Gritstone bio Announces Publication of Interim Results from Phase 1 Study of Self-amplifying mRNA (samRNA) Vaccine Against COVID-19 in Nature Communications (GlobeNewswire)
Jun-01-23 04:30PM	Gritstone bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-24-23 05:00PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.68%
May-16-23 06:05AM	The Consensus EPS Estimates For Gritstone bio, Inc. (NASDAQ:GRTS) Just Fell Dramatically (Simply Wall St.) -5.08%
May-11-23 04:05PM	Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates (GlobeNewswire) -9.96%
May-03-23 07:00AM	Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023 (GlobeNewswire)
Apr-21-23 06:05AM	Both individual investors who control a good portion of Gritstone bio, Inc. (NASDAQ:GRTS) along with institutions must be dismayed after last week's 14% decrease (Simply Wall St.)
Apr-17-23 07:01AM	Gritstone bio Presents 6-month Neutralizing Antibody (nAb) Data at ECCMID 2023 from Two Phase 1 Studies Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 (CORAL) (GlobeNewswire) -5.94%
07:00AM	Gritstone bio Presents Advances in Neoantigen Prediction and Cancer Vaccine Immunogenicity at the 2023 AACR Annual Meeting (GlobeNewswire)
Apr-10-23 07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-04-23 06:30PM	Gritstone bio Announces Presentations Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 at ECCMID 2023 (GlobeNewswire) -8.33%
Mar-15-23 07:00AM	Gritstone bio Announces Presentations on Neoantigen Prediction Capabilities and Cancer Vaccine Programs at the 2023 AACR Annual Meeting (GlobeNewswire)
Mar-11-23 07:18AM	Gritstone bio Full Year 2022 Earnings: Beats Expectations (Simply Wall St.)
Mar-09-23 04:05PM	Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates (GlobeNewswire) -7.79%
Mar-02-23 07:00AM	Gritstone bio to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 9, 2023 (GlobeNewswire)
Feb-27-23 04:06PM	Gritstone bio to Participate in 43rd Annual Cowen Healthcare Conference (GlobeNewswire)
04:05PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-14-23 07:00AM	Gritstone bio and the National Cancer Institute (NCI) Establish a Clinical Trial Agreement to Evaluate a Neoantigen Cell Therapy-Vaccine Combination (GlobeNewswire)
Jan-25-23 05:34AM	Investors in Gritstone bio (NASDAQ:GRTS) have unfortunately lost 66% over the last three years (Simply Wall St.)
Jan-24-23 07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-18-23 05:30PM	Gritstone bio to Participate in Upcoming Investor Conferences (GlobeNewswire) -7.58%
Dec-15-22 04:31PM	Gritstone bio to Present at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -8.67%
04:30PM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-13-22 07:00AM	Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA) (GlobeNewswire) +20.54%
Dec-05-22 08:30AM	Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors (GlobeNewswire)
Nov-21-22 07:30AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-17-22 07:00AM	Gritstone to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-10-22 09:00AM	Gritstone Announces Updated Overall Survival Results from GRANITE Phase 1/2 Study and Poster at SITC 2022 (GlobeNewswire) +15.74%
Nov-03-22 06:04PM	How biotech companies are building drug pipelines with PIPEs (American City Business Journals) +7.67% -14.56%
04:05PM	Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Oct-25-22 07:01AM	Gritstone bio Announces Private Placement of $45.0 Million (GlobeNewswire) +8.41%
07:00AM	Gritstone Presents Positive Results from Two Phase 1 CORAL Studies, Providing Further Proof-of-Concept for Self-amplifying mRNA (samRNA) in Infectious Diseases (GlobeNewswire)
Oct-19-22 09:43AM	Gritstone bio, Inc.'s (NASDAQ:GRTS) largest shareholders are individual investors with 48% ownership, institutions own 32% (Simply Wall St.)
07:00AM	Gritstone to Host Data Update on CORAL and Discuss the Application of Self-amplifying mRNA (samRNA) in Infectious Diseases (GlobeNewswire)
Oct-17-22 07:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-20-22 07:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-12-22 07:00AM	Gritstone Presents Positive Initial Phase 2 Data in Late-Line Solid Tumor Patients Treated With KRAS-Directed Immunotherapy (SLATE) at ESMO 2022 (GlobeNewswire) +7.52%
Sep-01-22 04:05PM	Gritstone to Participate in Two Upcoming Investor Conferences (GlobeNewswire) +7.02%
Aug-17-22 07:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.79%
Aug-15-22 04:05PM	Nature Medicine Publishes Interim Results from Gritstone bios Phase 1/2 Study of GRANITE, Individualized Neoantigen Vaccine for Solid Tumors (GlobeNewswire) +16.71%
Aug-10-22 04:05PM	Gritstone Appoints Dr. Lawrence Larry Corey to its Board of Directors (GlobeNewswire)
Aug-04-22 04:05PM	Gritstone Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) +21.43%
Aug-01-22 06:38AM	Investors in Gritstone bio (NASDAQ:GRTS) have unfortunately lost 73% over the last three years (Simply Wall St.)
Jul-26-22 07:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-21-22 04:06PM	Gritstone to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 4, 2022 (GlobeNewswire)
04:05PM	Gritstone Establishes Credit Facility for Up to $80 Million with Hercules Capital and Silicon Valley Bank (GlobeNewswire)
Jul-05-22 08:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +10.98%
Jun-10-22 08:00AM	Gritstone Announces Results from Preclinical Study of its Self-amplifying mRNA (samRNA) Vaccine Against SARS-CoV-2 Published in Nature Communications (GlobeNewswire)

Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Allen Andrew R	PRESIDENT AND CEO	May 16 '24	Sale	0.75	24,263	18,156	985,360	May 17 09:58 PM
Jones Erin	EVP, CHIEF OPERATING OFFICER	May 16 '24	Sale	0.75	13,749	10,288	359,293	May 17 09:57 PM
Jooss Karin	SEE REMARKS	May 16 '24	Sale	0.75	13,749	10,288	683,526	May 17 09:57 PM
Economides Vassiliki	EVP, CHIEF FINANCIAL OFFICER	May 16 '24	Sale	0.75	13,749	10,288	262,437	May 17 09:55 PM
Hawryluk Matthew	EVP, CHIEF BUSINESS OFFICER	May 16 '24	Sale	0.75	9,259	6,929	313,931	May 17 09:56 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GRTS

Gritstone Bio Inc

Upgrade your FINVIZ experience